OSA-18 in Children With Mild Obstructive Sleep Apnea: Can it be a Helpful Decision Making Tool?
Connecticut Children's Medical Center · with ResMed Foundation · NCT05911646
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 3–12 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 130
- US sites recruiting
- 1
- Study start
- June 2, 2021
- Record last updated
- May 28, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The concept is a novel research idea that incorporates the potential impact of patient quality of life (QOL) on decision-making for treatment of mild obstructive sleep apnea (OSA). Our hypothesis is that in children with mild OSA there is significant conflict with parental decision-making; in the absence of significant sleep apnea, there is limited research regarding comparative efficacy of various treatment options. The impact of a QOL questionnaire can be a significant deciding factor and may help guide management decisions in such situations.
Being studied: OSA-18 Survey; Decisional Conflict (DCS)
Conditions: Apnea, Obstructive Sleep; Obstructive Sleep Apnea
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Parent/caregiver of child with an initial diagnosis mild obstructive sleep apnea defined as polysomnography AHI score between 1 and 5
- Parent/caregiver of child between 3 and 12 years of age
- Parent/caregiver of child who has been diagnosed with tonsillar hypertrophy grade 2 or higher
Exclusion Criteria
- Parent/caregiver of child diagnosed with a syndromic or known neurologic condition and/or multiple (more than two) medical cardiac or respiratory medical conditions
- Parent/caregiver of child who has previously underwent tonsillectomy
Recruiting US locations
Connecticut Children's Medical Center
Hartford, CT 06106
Site contact: Nancy Grover, MD · ngrover@connecticutchildrens.org
Study contacts (from the official record)
- Nancy Grover, MD · 860- 545- 9650 · ngrover@connecticutchildrens.org
- Cameron King, MA · 8608375595 · CKing02@connecticutchildrens.org
Similar studies in Connecticut
All sleep studies in Connecticut →- RecruitingHealthy volunteersEarly Phase 1
Mechanistic Studies of Psilocybin in Headache Disorders
Yale University
- Location
- West Haven, CT
- Eligibility basics
- Ages 21–70
- RecruitingPhase 3
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Janssen Research & Development, LLC
- Location
- Farmington, CT + 41 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Merck Sharp & Dohme LLC
- Location
- New Haven, CT + 12 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 40+